SEC Filing Details

Document Details

Filing Date
Apr 15, 2019
Document Date
Apr 15, 2019
Form Description
Registration of certain classes of securities 12(b) of the Securities Exchange Act
Filing Group
Registration Statements
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb